2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Til: new trials by email Literature Review of Til trials Research Report on Til
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment Cyclophosphamide, Fludarabine, Tumour Infiltrating Lymphocytes - Metastatic Melanoma | Phase 2 | Terminated | The Christie NHS Foundation Trust | 2 | 2014-03-01 | 2023-04-20 |
| Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma Cyclophosphamide, Fludarabine, Tumor Infiltrating Lymphocytes - Metastatic Melanoma, Skin Cancer | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 3 | 2011-05-01 | 2015-01-27 |
Melanoma (2) · Skin Neoplasms (1)
National Cancer Institute (NCI) (1) · The Christie NHS Foundation Trust (1)
United Kingdom (1) · United States (1)
Paul Lorigan, MD (1) · Robert E Hawkins, MD (1) · Steven A Rosenberg, M.D. (1)